Incidence of cardiac arrest increases with the indiscriminate use of dexmedetomidine: a case series and review of published case reports.
Dexmedetomidine has predictable, complex, and negative cardiovascular effects that lead to additional adverse effects such as bradycardia and hypotension in up to 42% of patients and might cause profound left ventricular dysfunction and refractory shock. Usually, these temporary effects can be successfully counteracted with atropine, ephedrine, and volume supplementation. Clinicians need to be well informed about the potential of dexmedetomidine to cause bradycardia, which may progress to pulseless electrical activity, particularly in patients older than 50 years and patients with cardiac abnormalities. Here, we report the clinical characteristics of six patients who were scheduled for various neurosurgical procedures within a period of three months and suffered from cardiac arrest following dexmedetomidine administration. We urge clinicians to take caution against the negative effects of dexmedetomidine, especially when it is used in patients older than 50 years with underlying cardiac disease and in combination with cardiodepressant drugs.
Department of Anaesthesiology, Calcutta National Medical College, Kolkata, India. esbee77@rediffmail.com
Saswata
S
Bharati
Anirban
A
Pal
Chaitali
C
Biswas
Rajasree
R
Biswas
D000293:Adolescent; D058647:Adrenergic alpha-2 Receptor Agonists / Q000009:adverse effects*; D000368:Aged; D020927:Dexmedetomidine / Q000009:adverse effects*; D006323:Heart Arrest / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged
D058647:Adrenergic alpha-2 Receptor Agonists; D020927:Dexmedetomidine